Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers

Richard W. Joseph, Alicia C. Shillington, Todd A. Lee, Cynthia P. Macahilig, Scott J. Diede, Vaidehi Dave, Qing Harshaw, Emilie Scherrer, Frank Xiaoqing Liu

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences